Latest Articles

In this opinion piece, Vikram Savkar explores the potential impacts of ChatGPT and some of the concerns about the use of the technology.

Electronic pipettes offer several benefits, but many laboratories are still resistant to making the switch from manual options. This article discusses how equipping your team with electronic pipettes could rapidly pay for itself.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

The 11th-hour passage of The FDA Modernization Act gave a much-needed boost to the advocates of new alternative methods (NAMs) for preclinical testing. In this article, we take a look at why NAMs are needed and what the new legislation means for pharmaceutical companies.

Regulators are increasingly collaborating on a global scale, sharing expertise across regions for mutual benefit. In this article, Piety Rocha examines this upward trend.

This article will discuss the principles of fragment-based drug discovery and will highlight some examples of recent successes in this area.

In this opinion piece, Han Wei and Brittany Niccum outline the need for vigilance about what’s happening in the natural world and how collaboration can help to identify and prepare for the next significant zoonotic threat.

Structural biology uses a variety of techniques to determine the 3D structures of biomolecules such as proteins, nucleic acids and their complexes. In this article, we consider the key techniques, their role in structural biology, strengths and limitations.

Variation is a powerful force in biology. This article explores the importance of moving away from one-size-fits-all approaches and towards diversifying cell lines and clinical trials.

In this article, Michael Landau outlines factors driving biopharma companies to rely on CDMOs and highlights some of the contributions that CDMOs bring to their customers.